HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GOP Request To Stall New Rules: Post-Election Business As Usual On Capitol Hill

This article was originally published in The Rose Sheet

Executive Summary

House Republican leaders' request that federal agencies halt rulemaking until Trump's inauguration was not unexpected and their request tracks with the president-elect's priority for trimming regulations. "I think it was really a move to stop the administration from trying to legislate by fiat," says NPA chief Daniel Fabricant.

You may also be interested in...



After 10 Years, Congressional Supplement Caucus Sustains Momentum

At its start in 2006 and for a few subsequent sessions, the caucus wasn't well known and receiving the Administration Committee's acknowledgement that it was an authorized congressional membership group wasn't routine. Returning members had to renew their membership with each session, too.

Freedom Caucus Hit List Includes Antibacterial Soap, Supplement Label Rules

The caucus of 36 conservative Republicans lists 200 rules passed during the Obama administration, or the that president established through executive orders, that it recommends striking altogether or changing to lessen industries' regulatory burden.

FDA Guidance Makes Vinpocetine Compliant Despite Ban Proposal – NPA

NPA CEO Daniel Fabricant says some vinpocetine product marketers don't realize the ingredient's status as an active moiety of a botanical long used in the food supply, a knowledge gap obscures that FDA is using an extra-regulatory procedure to remove vinpocetine.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108710

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel